Back
23 October 2025
The ITA reports that triathlete Baqer Idrees has agreed¹ to the consequences imposed for his anti-doping rule violation (“ADRV”).
The athlete provided a sample on 11 November 2023 during the 2023 Asia Triathlon Sprint Championships held in Al-Khobar (Saudi Arabia) which yielded an adverse analytical finding² (AAF) for prednisone and prednisolone.
Prednisone and prednisolone are prohibited under the WADA Prohibited List in the category of S9. Glucocorticoids. These substances are prohibited in-competition only and are classified as specified substances. Glucocorticoids can enhance performance by reducing inflammation in the body and/or treating injuries or asthma.
The athlete did not challenge the ADRV and agreed with the consequences proposed by the ITA, namely a period of ineligibility of two years from 8 September 2025 until 7 September 2027 and disqualification of competitive results from 11 November 2023 onwards.
The relevant stakeholders, namely the World Anti-Doping Agency and the National Olympic Committee of Iraq, have a right to appeal the consequences imposed before the appeals division of the Court of Arbitration for Sport.
The ITA will not comment further on this case.
¹Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 and 8.3.3 of the World Triathlon anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed a World Triathlon/ITA decision. The athlete’s National Anti-Doping Organisation and the World Anti-Doping Agency have the right to appeal the agreement on consequences before the competent appeal body.
²A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.
